Introduction
The array of cytokines produced by T helper cells largely determines the protective value of the immune response. For example, T helper type 1 (Thi ) 1 cells (producing high levels of LFN-'y and no IL-4) confer resistance against pathogens with an obligatory or facultative intracellular cycle, whereas Th2 cells (producing high levels of and little or no IFN-y) are 1 . Abbreviations used in this paper: CBMC, cord blood mononuclear cells; NK, natural killer; PE, phycoerythrin-conjugated; r, recombinant; TCR, T cell receptor; Thl, T helper type 1. inefficient and may even aggravate such infections (1) (2) (3) (4) (5) (6) (7) . The development of a predominantly Thl-or Th2-like immune response is influenced greatly by the cytokines released by cells of the first line of defense of the organism, i.e., phagocytes, natural killer (NK) cells, and perhaps also mast cells/basophils and yy/6 T cells (7) (8) (9) (10) (11) (12) . IL-12 is rapidly released together with TNF-a, 1L-1, and 1L-6 by phagocytic cells exposed to bacterial or viral antigens ( 13 ) . These cytokines act in synergy on resting T cells and NK cells to induce IFN-y production, which in turn increases the bactericidal activity of phagocytes (9, 12, 14) . In addition to its important role in natural immunity, IL-12 also promotes the development of ThI responses in vivo and in vitro (15) (16) (17) (18) (19) , an effect which is dependent partly upon its ability to induce IFN-y production (15, 17) . Treatment of BALB/c mice with exogenous IL-12 at the time of inoculation of the parasite Leishmania major switches their immune response from a Th2 to a ThI phenotype and confers complete resistance to this otherwise lethal infection (15, 16) . In vitro, Ag stimulation of naive T cells from T cell receptor (TCR) transgenic mice in the presence of IL-12 leads to the development of effector cells producing high levels of IFN-y and no 1L-4; reciprocally after priming in the presence of 1L-4, these TCR transgenic naive T cells acquire a Th2 phenotype (17, 18, 20, 21) .
In the human system, IL-12 was reported to switch the in vitro recall response of allergen-specific T cells of atopic donors from a Th2-to a Thl-like phenotype (22) . Hence, addition of IL-12 to PBMC cultures stimulated with allergen leads to the generation of Thi /ThO, instead of Th2-like allergen-specific T cell lines or clones. In contrast to in vivo observations in mice ( 15, 16) (24) . Taken together, these studies indicated that IL-12 may not only promote the expression of IFN-y but also of IL-4 during the maturation of neonatal human CD4 T cells. It was hypothesized that the paradoxical effects of IL-12, as well as of IL-4, might be accounted for by the resting stage of the cells which were not stimulated via the TCR/CD3 complex at the time of exposure to the cytokines. Indeed, it was subsequently observed that 11-4 promotes the development of anti-CD3-activated neonatal CD4 T cells into Th2-like effector cells (25) . Here we report the unexpected finding that neonatal cells primed in the presence of IL-12 acquire the capacity to produce high levels of IL-4 as well as IFN-y. However "naive" CD4 T cells isolated as CD45RO-CD4+ T cells from the blood of healthy adults develop into typical Thl cells after priming in the presence of IL-12.
Methods
Reagents. Human recombinant (r) IL-12 was produced and purified as described (26) ; its specific activity was 3 x 108 U/mg, as measured in the human PHA blast proliferation assay (27 Purification of cells. Human umbilical cord blood was drawn on heparin before expulsion of the placenta, and cells were prepared as described (23) (24) (25) . Briefly, mononuclear cells were obtained by centrifugation on Ficoll-Metrizoate gradients and treated with L-leucyl methyl esther to remove monocytes and NK cells. They were enriched in T cells by rosetting with S-(2-aminoethyl) isothiouronium bromide (Aldrich Chemical Co., Milwaukee, WI) treated sheep red blood cells, and rosette-forming (T) cells were treated with Lympho-Kwik TH (One Lambda, Canoga Park, CA). Adult CD4 T cells isolated under the same conditions were depleted in CD45RO+ cells by means of a FACSort (Becton Dickinson Canada). To examine the purity of the cellular preparations, cells were stained using optimal concentrations of PE-or FITCconjugated mAbs or isotype-matched control mAbs for 30 min on ice; washed cells were then analyzed by flow cytometry. Neonatal CD4 T cell preparations were > 98% viable (trypan blue negative), were > 97% CD4+, and were < 1% CD8+, CD16+, CDl9+, CD56+, or FceRl +; adult CD45RO -CD4 cells were < 1% CD45RO +.
Culture conditions. Neonatal CD4 T cells (0.5 x 106/ml) were cultured in RPMI 1640 medium containing 10% FCS, 5 mM L-glutamine, 50 IU penicillin G, and 50 mg/ml streptomycin in 24-well tissue culture plates (1 ml/well). Anti-CD3 mAb 64.1 (50 ng/ml) in the presence of irradiated (6,500 rad) CD32-transfected mouse L fibroblasts (0.25 X 106/ml) was used to activate the cells; after 3 d, cells were washed and expanded in fresh medium containing 50 IU/ml of IL-2 in 24-well plates for an additional 4 d. Recovery of viable cells at day 7 was around 10 times (8-12) the initial amount, and viability was > 98%. Washed cells (0.5 x 106/ml) were restimulated with either anti-CD3 mAb 64.1 (50 ng/ml) and anti-CD28 mAb (0.5 gg/ml) immobilized on irradiated CD32+ L cells (0.25 x 106/ml) or with PMA (10 ng/ml) plus ionomycin (1 pg/ml); supernatant was collected after 48 h for cytokine titration.
Lymphokine measurement. Lymphokines were measured exactly as in our previous studies (23) (24) (25) by using two-site sandwich ELISA or RIA, using a mouse mAb as capture antibody (Ab) and either monoclonal or polyclonal Ab for detection. Capture mAb to IL-4 (clone 3H4) and IFN-y (clone 42103) are kind gifts of Dr. C. Heusser (CIBA-GEIGY). Polyclonal rabbit anti-IL-4 and LFN-y have been produced and used as described previously (24 (Fig. 1 A) or with PMA plus ionomycin ( Fig. 1 B) to examine their cytokine production. As seen, cells primed in the presence of IL-12 produce high levels of both IL-4 and IFN-y, whereas their production of IL-0 is reduced (70% inhibition, P < 0.01 ), and that of IL-5 is unchanged. As Resting neonatal cells preincubated with IL-12 fail to develop into IL4-producing effector cells. We reported previously that, after preincubation with IL-12, neonatal CD4 T cells become capable of producing high levels of IFN-y but no IL-4 upon primary stimulation in the absence of exogenous cytokine (23). Here we have examined whether preincubation of resting neonatal cells with IL-12 before their activation by anti-CD3 would prevent the development of IL-4-producing cells. To this end, unstimulated CD4 cells were first cultured with or without IL-12 together with IL-1 (1 ng/ml) and TNFa (200 ng/ml), which are known to synergize with IL-12 for the induction of IFN-y production (23) . At day 3, cultures were supplemented with anti-CD3 mAb and irradiated CD32-transfected fibroblasts; one set of control cultures was also supplemented at this time with 1L-12, 1L-1, and TNF-a. After 3 d of stimulation with anti-CD3, T cells were collected, expanded in the presence of IL-2, and examined for cytokine production in response to anti-CD3 plus anti-CD28 stimulation. The results clearly indicate that cells which have been preincubated with IL-12 differentiate into Thl-type effector cells after priming in the presence of 1L-12 (Fig. 4) , whereas, as expected, cells preincubated in culture medium alone and activated in the presence of 1L-12 (together with 1L-1 and TNF-a ) differentiate into IL-4-and IFN-y-producing cells. Moreover, cells preincubated with IL-1 plus TNF-a displayed the same response as control cells preincubated in culture medium alone (data not detailed).
Discussion
We here report the unexpected finding that 1L-12 exerts a differential effect on the maturation of CD45RO -CD4 T cells isolated from umbilical cord blood or from the blood of healthy adults. The present observation that IL-12 directs the development of anti-CD3-activated adult CD45RO -T cells into ThI-like cells is in complete agreement with previous studies in the mouse using spleen T cells of young adult animals as a source of naive cells (17, 18) . Most strikingly, unlike their adult counterparts, neonatal CD4+ T cells primed in the presence of IL-12 produce high levels of IL-4, in addition to IFN-y, on restimulation with either PMA plus ionomycin or anti-CD3 plus anti-CD28 mAbs presented on CD32-transfected L fibroblasts. Moreover, these cells produce the same levels of IL-5 but much less IL-10 than control cells primed in the absence of IL-12. This cytokine (29) . The addition of IL-12 to mouse spleen T cells activated by plastic-bound anti-CD3 in the presence of IL-4 was found to significantly enhance IL-4 production by the primed T cells without increasing their production of IFN-y (29) . The effect of IL-12 on the maturation of neonatal T cells is direct inasmuch as it is observed on highly purified CD4 T cells (> 99% CD3 +, > 97% CD4 +). Of interest, the same effect is also observed if the CD4' T cells are primed in the presence of NK cells and CD8 T lymphocytes that are known to release high levels of IFN-y in response to IL-12. The data therefore imply that IFNy does not ablate the enhancing effect of IL-12 on IL-4 expression by neonatal cells. This view is supported by the previous observation that the addition of neutralizing IFN-y mAb to resting neonatal cells maintained in IL-4 plus IL-12 supplemented medium does not enhance their maturation into high IL-4 producers (24) .
Neonatal CD4 T cells are phenotypically and functionally very similar to adult CD4+ CD45R0-T cells: (a) they do not respond to soluble Ags; (b) they do not help B cells for Ig production but rather induce suppressor cell activity; (c) on stimulation they release IL-2 but little or no IFN-y, IL-4, 1L-5, and 1L-10; (d) they are homogenously CD45RA9igh/R0'°r-, CD25 -, and HLA-DR-; and (e) they express the same levels of CD31 (23, 24, (30) (31) (32) (33) (34) (35) . These similarities, together with the fact that after activation they both acquire the typical phenotypic and functional features of "memory" T cells, prompted several investigators to consider that adult and neonatal CD4 + CD45RO-T cells are immunologically naive or Ag inexperienced (32, 34) . The finding that IL-12 exerts a differential effect on the maturation of activated neonatal versus adult CD45RO-T cells indicates that these two types of cells are functionally different and is taken to illustrate the immaturity of umbilical cord blood T cells. It must be related to recent observations that neonatal T cells express less CD3 and much more CD38 than adult CD45RO-cells from which however they do not differ by the expression of 1L-2, 1L-4, and IFN-y mRNA (30, (35) (36) (37) . It is likely that, in the neonates as opposed to the adults, the pool of peripheral CD4+ T cells contains a large proportion of recent CD4 + CD8 -thymic emigrants which bear the same levels of CD3 and CD38 and which, upon activation, express the same pattern of cytokine mRNA as umbilical cord blood CD4 T cells (30, (35) (36) (37) CD45R0+/RA-to CD45R0-/RA+ (38, 39) . Indeed, such a phenotypic conversion has been observed both in vivo and in vitro (40) (41) (42) . The postnatal maturation of T cells is probably a complex phenomenon which reflects (a) the progressive exposure of the organism to several microbes and antigens; (b) the so-called postthymic maturation of recent thymic emigrants (43) ; and (c) a drastic change in the hormonal and cytokine milieu to which resting naive T cells are exposed. Steroid hormones were reported to exert differential effects on the expression of Thl versus Th2 cytokines (44) (45) (46) , and maternal lymphocytes recovered from the placental interphase preferentially express Th2-like cytokines (47) . Given that IL-12 is produced mainly in response to bacterial antigens (13) and that there is no bacterial colonization during the intrauterine life, it is likely that the production of IL-12 is very low during that period. Supporting the role of the cytokine milieu to which naive cells are exposed before their first encounter with Ag are the present observations that neonatal cells preincubated with IL-12 before anti-CD3 stimulation respond like adult naive CD4 T cells on priming in the presence of 1L-12 and develop into Thl-like cells.
If applicable in vivo, the finding that IL-12 promotes 11L-4 expression in neonatal CD4 T cells may have considerable clinical implications. Hence, several pathogens which induce a rapid production of IL-12 leading a protective Thl response in adults would trigger high levels of 1L-4 production in neonates. Given that 11L-4 inhibits not only the development of Thl type effector cells but also the release and the function of Thl cytokines, including the enhancement of macrophage bactericidal activity (6, 48, 49) , the present findings should be related to the increased severity or chronicity of certain congenital or perinatal infections. For example, over 90% of newborns infected with hepatitis B virus develop a chronic infection which is clinically silent but may predispose to the development of hepatocellular carcinoma; in contrast, over 90% of adults infected with hepatitis B virus develop a ThI-mediated acute inflammatory response resulting in the elimination of the virus (50, 51 ) . Similar considerations may explain the severity of neonatal infections with several viruses and bacteria such as herpes simplex virus (52), listeria monocytogenesis (53) , and mycobacterium tuberculosis (54) . Given that low progression or "resistance" to HIV infection is associated with preferential expression of Thl cytokines and that, conversely, progression of the disease is associated with dominant expression of Th2 cytokines, it is reasonable to speculate that the more rapid evolution of neonatal HIV infection is related to the early expression of IL-4 (2). The preventive value of BCG vaccination remains diversely appreciated (54) , and it was reported recently that BCG given during the first 3 d of life is much less efficient and generates more complications than when given after 3 mo (55) . These unpublished observations). In conclusion, the present finding that the effect of IL-12 is greatly influenced by the age of the T cell donor may explain the increased susceptibility of neonates to certain infections and should be taken into consideration for the utilization of vaccines in the neonatal period.
